Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia-Reference-Cited by-同舟云学术

Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia

Published:2021-03-15 Issue:4 Volume:15 Page:7547-7562
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Ribera Jordi¹,Vilches Clara²^ORCID,Sanz Vanesa²,de Miguel Ignacio²,Portolés Irene¹,Córdoba-Jover Bernat¹,Prat Esther³⁴,Nunes Virginia³⁴,Jiménez Wladimiro¹⁵,Quidant Romain²⁶^ORCID,Morales-Ruiz Manuel¹⁵

Affiliation:

1. Biochemistry and Molecular Genetics Department, Hospital Clínic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 08008 Barcelona, Spain

2. Institut de Ciències Fotòniques (ICFO), The Barcelona Institute of Science and Technology, 08860 Castelldefels, Barcelona, Spain

3. Molecular Genetics Laboratory, Genes, Disease and Therapy Programme, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), 08908 L’Hospitalet de Llobregat, Barcelona, Spain

4. Department of Physiology, Health Science and Medicine Faculty, University of Barcelona (UB), 08908 L’Hospitalet de Llobregat, Barcelona, Spain

5. Department of Biomedicine-Biochemistry Unit, School of Medicine, University of Barcelona (UB), 08008 Barcelona, Spain

6. Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain

Funder

Fundaci??n Cellex

European Commission

Ministerio de Econom??a y Competitividad

Generalitat de Catalunya

Centro de Investigaci??n Biom??dica en Red de Enfermedades Hep??ticas y Digestivas

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c00988

Reference60 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Liver fibrosis

3. History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells

4. Regulation of PDGF and its receptors in fibrotic diseases

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment;Biomedicines;2024-08-16

2. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems;ACS Nano;2024-07-31

3. Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders;Heliyon;2024-02

4. Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy;ACS Nano;2024-01-30

5. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents;Journal of Materials Chemistry B;2024